International Journal of Nanomedicine,
Journal Year:
2022,
Volume and Issue:
Volume 17, P. 1365 - 1379
Published: March 1, 2022
Background:
Low
delivery
efficiency
of
nanoparticles
(NPs)
to
the
tumor
is
a
critical
barrier
in
field
cancer
nanomedicine.
Strategies
on
how
improve
NP
remain
be
determined.
Methods:
This
study
analyzed
roles
physicochemical
properties,
models,
and
types
using
multiple
machine
learning
artificial
intelligence
methods,
data
from
recently
published
Nano-Tumor
Database
that
contains
376
datasets
generated
physiologically
based
pharmacokinetic
(PBPK)
model.
Results:
The
deep
neural
network
model
adequately
predicted
different
NPs
tumors
it
outperformed
all
other
methods;
including
random
forest,
support
vector
machine,
linear
regression,
bagged
methods.
adjusted
determination
coefficients
(R
2
)
full
training
dataset
were
0.92,
0.77,
0.77
0.76
for
maximum
(DE
max
),
at
24
h
168
last
sampling
time
Tlast
).
corresponding
R
values
test
0.70,
0.46,
0.33
0.63,
respectively.
Also,
this
showed
type
was
an
important
determinant
predicting
across
endpoints
(19–
29%).
Among
Zeta
potential
core
material
played
greater
role
than
such
as
type,
shape,
targeting
strategy.
Conclusion:
provides
quantitative
design
nanomedicine
with
efficiency.
These
results
help
our
understanding
causes
low
demonstrates
feasibility
integrating
PBPK
modeling
approaches
Graphical
Abstract:
Keywords:
intelligence,
learning,
modeling,
nanomedicine,
drug
delivery,
nanotechnology
Advanced Functional Materials,
Journal Year:
2021,
Volume and Issue:
31(18)
Published: Feb. 19, 2021
Abstract
In
tumor
therapy,
nanodrug
delivery
systems
have
gained
momentum
in
the
last
decade.
However,
its
efficacy
remains
insufficient
for
clinical
applications.
The
physical
properties
of
nanoparticles,
including
size,
shape,
and
surface
characteristics,
can
strongly
affect
efficacy.
Ironically,
research
on
shape
function
is
relatively
scarce,
although
nanoparticle
greatly
impacts
their
performance;
example,
nanorods
with
a
high
aspect
ratio
(AR)
achieve
greater
accumulation,
but
penetration
weak.
Hence,
rather
than
selecting
suitable
AR
to
balance
them,
strategy
transformable
(i.e.,
transformation)
ideal
this
case.
Nanoparticle
transformation
be
achieved
by
either
internal
stimuli
(such
as
pH
enzymes)
or
external
light)
spatially
temporally
precision,
thereby
dramatically
enhancing
efficiency
drug
delivery.
Thus,
becoming
promising
prospect
improving
cancer
treatment.
review,
first,
effect
summarized,
then,
recently
are
reviewed,
finally,
future
direction
shape‐transformable
nanoparticles
therapy
discussed.
Chemical Reviews,
Journal Year:
2021,
Volume and Issue:
121(18), P. 11653 - 11698
Published: Feb. 10, 2021
In
recent
decades,
peptides,
which
can
possess
high
potency,
excellent
selectivity,
and
low
toxicity,
have
emerged
as
promising
therapeutics
for
cancer
applications.
Combined
with
an
improved
understanding
of
tumor
biology
immuno-oncology,
peptides
demonstrated
robust
antitumor
efficacy
in
preclinical
models.
However,
the
translation
intracellular
targets
into
clinical
therapies
has
been
severely
hindered
by
limitations
their
intrinsic
structure,
such
systemic
stability,
rapid
clearance,
poor
membrane
permeability,
that
impede
delivery.
this
Review,
we
summarize
advances
polymer-mediated
delivery
therapy,
including
both
therapeutic
peptide
antigens.
We
highlight
strategies
to
engineer
polymeric
materials
increase
efficiency,
especially
cytosolic
delivery,
plays
a
crucial
role
potentiating
peptide-based
therapies.
Finally,
discuss
future
opportunities
treatment,
emphasis
on
design
polymer
nanocarriers
optimized
Biomaterials Science,
Journal Year:
2021,
Volume and Issue:
9(8), P. 2825 - 2849
Published: Jan. 1, 2021
Metal-phenolic
networks
(MPNs)
have
shown
promising
potential
in
biomedical
applications
since
they
provide
a
rapid,
simple
and
robust
way
to
construct
multifunctional
nanoplatforms.
As
novel
nanomaterial
self-assembled
from
metal
ions
polyphenols,
MPNs
can
be
prepared
assist
the
theranostics
of
cancer
owing
their
bio-adhesiveness,
good
biocompatibility,
versatile
drug
loading,
stimuli-responsive
profile.
This
Critical
Review
aims
summarize
recent
progress
MPN-based
nanoplatforms
for
multimodal
tumor
therapy
imaging.
First,
advantages
as
carriers
are
summarized.
Then,
various
therapeutic
modalities
based
on
introduced.
Next,
theranostic
systems
reviewed.
In
terms
vivo
applications,
specific
attention
is
paid
biosafety,
biodistribution,
well
excretion.
Finally,
some
problems
limitations
discussed,
along
with
future
perspective
field.
Redox Biology,
Journal Year:
2021,
Volume and Issue:
45, P. 102046 - 102046
Published: June 15, 2021
SARS-CoV-2
has
caused
up
to
127
million
cases
of
COVID-19.
Approximately
5%
COVID-19
patients
develop
severe
illness,
and
approximately
40%
those
with
illness
eventually
die,
corresponding
more
than
2.78
people.
The
pathological
characteristics
resemble
typical
sepsis,
been
identified
as
viral
sepsis.
Progress
in
sepsis
research
is
important
for
improving
the
clinical
care
these
patients.
Recent
advances
understanding
pathogenesis
have
led
view
that
an
uncontrolled
inflammatory
response
oxidative
stress
are
core
factors.
However,
traditional
treatment
it
difficult
achieve
a
balance
between
inflammation,
pathogens
(viruses,
bacteria,
fungi),
patient
tolerance,
resulting
high
mortality
In
recent
years,
nanomaterials
mediating
reactive
oxygen
nitrogen
species
(RONS)
shown
previously
unattainable
therapeutic
effects
on
Despite
advantages,
RONS
response-based
yet
be
extensively
adopted
therapy.
To
best
our
knowledge,
no
review
discussed
application
nanomaterials.
help
bridge
this
gap,
we
discuss
related
inflammation
overproduction
RONS,
which
activate
pathogen-associated
molecular
pattern
(PAMP)-pattern
recognition
receptor
(PRR)
damage-associated
(DAMP)-PRR
signaling
pathways.
We
also
summarize
As
highlighted
here,
strategy
could
synergistically
improve
efficacy
against
both
may
prolong
survival.
Current
challenges
future
developments
summarized.
International Journal of Nanomedicine,
Journal Year:
2022,
Volume and Issue:
Volume 17, P. 1365 - 1379
Published: March 1, 2022
Background:
Low
delivery
efficiency
of
nanoparticles
(NPs)
to
the
tumor
is
a
critical
barrier
in
field
cancer
nanomedicine.
Strategies
on
how
improve
NP
remain
be
determined.
Methods:
This
study
analyzed
roles
physicochemical
properties,
models,
and
types
using
multiple
machine
learning
artificial
intelligence
methods,
data
from
recently
published
Nano-Tumor
Database
that
contains
376
datasets
generated
physiologically
based
pharmacokinetic
(PBPK)
model.
Results:
The
deep
neural
network
model
adequately
predicted
different
NPs
tumors
it
outperformed
all
other
methods;
including
random
forest,
support
vector
machine,
linear
regression,
bagged
methods.
adjusted
determination
coefficients
(R
2
)
full
training
dataset
were
0.92,
0.77,
0.77
0.76
for
maximum
(DE
max
),
at
24
h
168
last
sampling
time
Tlast
).
corresponding
R
values
test
0.70,
0.46,
0.33
0.63,
respectively.
Also,
this
showed
type
was
an
important
determinant
predicting
across
endpoints
(19–
29%).
Among
Zeta
potential
core
material
played
greater
role
than
such
as
type,
shape,
targeting
strategy.
Conclusion:
provides
quantitative
design
nanomedicine
with
efficiency.
These
results
help
our
understanding
causes
low
demonstrates
feasibility
integrating
PBPK
modeling
approaches
Graphical
Abstract:
Keywords:
intelligence,
learning,
modeling,
nanomedicine,
drug
delivery,
nanotechnology